Literature DB >> 3902983

Early neonatal group B streptococcal disease: degree of colonisation as an important determinant.

L J Gerards, B P Cats, J A Hoogkamp-Korstanje.   

Abstract

During a period of 5 years (1 January 1977 to 1 January 1982) 145 infants colonised with group B streptococci (GBS) were admitted to the neonatal intensive care unit of the University Children's Hospital, Utrecht. In 87 of these infants (60%) vertical transmission of GBS was established; in 43 of these 87 infants (49%) the degree of colonisation was moderate to heavy. Early-onset (EO) GBS disease arose in 21 of 145 infants (attack rate: 14.5%). Of the 43 infants moderately to heavily colonised with GBS, however, 19 suffered from EO GBS disease (attack rate: 44.2%), whereas there were only two cases among the 44, lightly colonised infants (attack rate: 4.5%), a highly significant difference (P less than 0.0005). Similarly, probable sepsis (PS), defined as signs and symptoms of sepsis but without positive blood cultures, was observed significantly more often in moderately to heavily colonised infants (15/43, attack rate: 34.9%) compared with those lightly colonised (4/44, attack rate: 9.1%) (P less than 0.005). Infants moderately to heavily colonised with GBS at birth appear to have a significantly higher risk of developing serious GBS disease (EO or PS) than do infants only lightly colonised.

Entities:  

Mesh:

Year:  1985        PMID: 3902983     DOI: 10.1016/s0163-4453(85)91955-3

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  6 in total

1.  Outbreak of late-onset group B streptococcal infections in healthy newborn infants after discharge from a maternity hospital: a case report.

Authors:  Hyung Jin Kim; Soo Young Kim; Won Hee Seo; Byung Min Choi; Young Yoo; Kee Hyoung Lee; Baik Lin Eun; Hai Joong Kim
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

2.  Prevalence and significance of group B Streptococcus in a large obstetric population.

Authors:  A K Joshi; C I Chen; R W Turnell
Journal:  CMAJ       Date:  1987-08-01       Impact factor: 8.262

3.  In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin G.

Authors:  L Tissi; C von Hunolstein; P Mosci; C Campanelli; F Bistoni; G Orefici
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

4.  Efficacy of a universal screening program for the prevention of neonatal group B streptococcal disease.

Authors:  M de Cueto; M J Sánchez; L Moltó; J A Miranda; A J Herruzo; A Ruiz-Bravo; M de la Rosa-Fraile
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

Review 5.  Epidemiology of group B streptococcal disease in the United States: shifting paradigms.

Authors:  A Schuchat
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

6.  Significance of Gram's stain in rapid intrapartum screening for maternal carriership of group B streptococcus.

Authors:  A H Adriaanse; H L Muytjens; L A Kollée; J G Nijhuis; J A Hoogkamp-Korstanje
Journal:  Infect Dis Obstet Gynecol       Date:  1995
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.